Venus Concept Receives FDA 510(k) Clearance of Venus BlissMAX
Venus Concept Inc announces it has received 510(k) clearance from the US Food and Drug Administration to market the Venus BlissMAX device in the United States.
Tag: Venus Concept Inc
All
Popular
All
LatestSorry, No Posts Found
All
Latest
New Short-Term Botox-Like Treatment Moves Closer to FDA Review
The neurotoxin is characterized by a rapid onset of action as early as eight hours after administration and a shorter duration of effect of two to three weeks.
